Nasa astronaut Anil Menon set off tonight on an eight-month mission to the International Space Station (ISS), where he will lead and participate in advanced scientific studies designed to support future deep-space exploration and develop innovations that could improve life on Earth.
The Indian-origin American astronaut travelled alongside two Russian cosmonauts aboard a Soyuz spacecraft that launched from the Baikonur Cosmodrome.
Trained in emergency and aerospace medicine, Menon will act both as an investigator and as a research subject during the extended stay in orbit.
His time in microgravity is expected to provide critical insights into the effects of long-duration spaceflight on the human body—information considered vital as Nasa and its global partners plan missions to the Moon and Mars.
Among the primary studies is the testing of an AI-powered ultrasound system intended to assist astronauts in conducting sophisticated medical scans in space, even when direct support from Earth-based physicians is limited.
This technology could prove indispensable on deep-space journeys, where communication delays would prevent real-time medical guidance from mission control.
Menon will also be involved in research focused on producing high-grade semiconductors in microgravity. Researchers believe that the near-weightless conditions in orbit may allow for the creation of more consistent and less flawed semiconductor materials, potentially transforming the development of high-performance computing, electronics, and communication technologies back on Earth.
The study of human physiology will be a central component of the mission. Menon will contribute to multiple investigations examining how extended exposure to weightlessness impacts circulation, heart function, and overall physical health. These findings are expected to help scientists design more effective strategies to safeguard astronauts on prolonged missions beyond low-Earth orbit.
Another significant experiment will focus on bioprinting in space, with scientists aiming to determine whether microgravity conditions can enhance the production of complex biological tissues.
Results from this research may advance understanding of the ageing process and aid in developing innovative treatments for age-related illnesses and regenerative medicine applications.
Menon’s professional background makes him especially well-qualified for this role. Prior to becoming a Nasa astronaut, he served as a flight surgeon, supporting both government and commercial space missions and bringing together expertise in emergency care and aerospace medicine.
Throughout the eight-month expedition, information gathered from the mission will support Nasa’s wider objective of ensuring safer and more sustainable human space travel.
The outcomes are expected to be instrumental in shaping upcoming Artemis missions to the Moon and, in the longer term, humanity’s first crewed journeys to Mars.